Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer. [PDF]
Taş H +15 more
europepmc +1 more source
Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer. [PDF]
Zavvar TS +13 more
europepmc +1 more source
Radioligand Therapy in Cancer Management: A Global Perspective. [PDF]
Ninatti G, Lee ST, Scott AM.
europepmc +1 more source
Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging. [PDF]
Obeid K +4 more
europepmc +1 more source
Potentials and practical challenges of terbium-161 labeled radiopharmaceuticals. [PDF]
Ntihabose CM +11 more
europepmc +1 more source
The Role of Radioligand Therapy in Gastroenteropancreatic Neuroendocrine Tumors: An Italian Expert Opinion. [PDF]
Tafuto S +12 more
europepmc +1 more source
Targeted radionuclide therapy and diagnostic imaging of SSTR positive neuroendocrine tumors: a clinical update in the new decade. [PDF]
Haugh KN, Sanwick AM, Chaple IF.
europepmc +1 more source
Linker Chemistry in Radiopharmaceutical Design. [PDF]
Stoddard A +5 more
europepmc +1 more source
The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review. [PDF]
Moghrabi S +8 more
europepmc +1 more source
Blood-based transcriptomic biomarkers for response to [<sup>177</sup>Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors. [PDF]
Sung H +6 more
europepmc +1 more source

